SOPHiA GENETICS is provided earnings guidance for 2024. For the period, company expects Revenue between $78 million and $81 million, representing growth of 25% to 30% compared to full year 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.975 USD | +0.51% |
|
+2.27% | +5.31% |
May. 29 | Sector Update: Health Care Stocks Fall Late Afternoon | MT |
May. 29 | Sophia Genetics Rallies Wednesday after Partnering with Microsoft, Nvidia on Whole Genome Analytics Platform | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.31% | 324M | |
+18.57% | 3,332B | |
+20.44% | 93.88B | |
+19.88% | 88.3B | |
+49.80% | 55.72B | |
-18.93% | 49.9B | |
+87.04% | 43.03B | |
-35.51% | 40.77B | |
-3.12% | 27.55B | |
-21.65% | 22.98B |
- Stock Market
- Equities
- SOPH Stock
- News SOPHiA GENETICS SA
- SOPHiA GENETICS SA Provides Earnings Guidance for 2024